Taking it one step further ... It wouldn't take much to reach 2012 highs with any positive indications on the trial front. If the Cramer rumor pushed us up in dramatic fashion can you imagine what the results of an indication can do ? I believe the immunotherapy arena has taken front and center stage. Pphm has the tool that bps want.
News 
Market Data 
Discover 
